Skip to main content
. 2025 Oct 9;13(4):52. doi: 10.3390/jmahp13040052
AEs Adverse Events
AMNOG Arzneimittelmarkt-Neuordnungsgesetz (German Pharmaceuticals Market Reorganisation Act)
CE Cost Effectiveness
EMA European Medicines Agency
EQ-5D EuroQoL-5D questionnaire
EU European Union
HTDs Health Technology Developers
HRQoL Health-Related Quality of Life
IQWiG Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (German Institute for Quality and Efficiency in Health Care)
LLMs Large Language Models
JCA Joint Clinical Assessment
NICE National Institute for Health and Care Excellence
NMA Network Meta-Analysis
PICO Population/Intervention/Comparator/Outcome
QALYs Quality Adjusted Life Years
OS Overall Survival
PFS/DFS/RFS Progression/Disease/Relapse-Free Survival
VAS Visual Analogue Scale